https://www.selleckchem.com/products/wnt-c59-c59.html The Hospital Frailty Risk Score (HFRS) is a validated geriatric comorbidity measure derived from routinely collected administrative data. The purpose of this study is to evaluate the utility of the HFRS as a predictor for postoperative adverse events after primary total hip (THA) and knee (TKA) arthroplasty. In a retrospective analysis of 8250 patients who had undergone THA or TKA between 2011 and 2019, the HFRS was calculated for each patient. Reoperation rates, readmission rates, complication rates, and transfusion rates were compared between patients with low and intermediate or high frailty risk. Multivariate logistic regression models were used to assess the relationship between the HFRS and postoperative adverse events. Patients with intermediate or high frailty risk showed a higher rate of reoperation (10.6% vs 4.1%, P < .001), readmission (9.6% vs 4.3%, P < .001), surgical complications (9.1% vs 1.8%, P < .001), internal complications (7.3% vs 1.1%, P < .001), other complications (24.4% vs 2.0%, P < .001), Clavien-Dindo grade IV complications (4.1% vs 1.5%, P < .001), and transfusion (10.4% vs 1.3%, P < .001). Multivariate logistic regression analyses revealed a high HFRS as independent risk factor for reoperation (odds ratio [OR]= 2.1; 95% confidence interval [CI], 1.46-3.09; P < .001), readmission (OR= 1.78; 95% CI, 1.21-2.61; P= .003), internal complications (OR= 3.72; 95% CI, 2.28-6.08; P < .001), surgical complications (OR= 3.74; 95% CI, 2.41-5.82; P < .001), and other complications (OR= 9.00; 95% CI, 6.58-12.32; P < .001). The HFRS predicts adverse events after THA and TKA. As it derives from routinely collected data, the HFRS enables hospitals to identify at-risk patients without extra effort or expense. Level III-retrospective cohort study. Level III-retrospective cohort study. Although extended trochanteric osteotomy (ETO) is an effective technique for femoral stem removal and for the concomitant